TLDR Baicalin may effectively treat hair loss by inhibiting 5α-reductase.
This study investigates baicalin's potential mechanism against androgenetic alopecia (AGA) using a network pharmacology approach. Researchers identified 18 overlapping targets between baicalin-related targets and AGA-associated genes, with key proteins including ALB, AKT1, AR, ESR1, and EGFR. The study highlights baicalin's involvement in hormone regulation and cellular proliferation pathways, particularly the estrogen signaling pathway. Molecular docking suggests baicalin binds effectively to type II 5α-reductase (SRD5A2) with a binding energy of −11.1 kcal mol⁻¹, forming stable hydrogen bonds, indicating its potential as an effective treatment for AGA by inhibiting 5α-reductase.
December 2024 in “Therapeutic Delivery” Topical dutasteride shows promise for hair loss but needs more research.
October 2023 in “Case Reports” A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.
2 citations
,
January 2022 in “BioMed Research International” Baicalin may help treat hair loss by promoting hair follicle growth and activating specific cellular pathways.
24 citations
,
August 2022 in “International Journal of Pharmaceutics” Glycyrrhizin nanocarriers effectively deliver baicalin to hair follicles, promoting hair growth and offering a promising alopecia treatment with fewer side effects.
Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.
February 2025 in “Journal of Nanobiotechnology” A new treatment using microneedles with black phosphorus and laser helps regrow hair effectively and safely.
June 2023 in “Food frontiers” Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.
5 citations
,
July 2003 in “Drug Development Research” Fluridil promotes hair growth safely and effectively for androgenetic alopecia.